97. 潰瘍性大腸炎
[臨床試験数:2,269,薬物数:1,331(DrugBank:241),標的遺伝子数:114,標的パスウェイ数:181

Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2015-003364-36-BG
(EUCTR)
09/02/201628/01/2016A study using a new drug (GED-0301) to investigate if the new drug works and is safe in subjects suffering ulcerative colitis.A Phase 2, Open-label, Multicenter Study to Explore the Efficacy and Safety of Mongersen (GED-0301) in Subjects with Active Ulcerative Colitis. Ulcerative Colitis.
MedDRA version: 18.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: Mongersen
Product Code: GED-0301
INN or Proposed INN: Mongersen
Other descriptive name: GED-0301
Celgene CorporationNULLNot RecruitingFemale: yes
Male: yes
40Phase 2United States;Hungary;Slovakia;Canada;Poland;Bulgaria
2EUCTR2015-003364-36-HU
(EUCTR)
09/02/201602/12/2015A study using a new drug (GED-0301) to investigate if the new drug works and is safe in subjects suffering ulcerative colitis.A Phase 2, Open-label, Multicenter Study to Explore the Efficacy and Safety of Mongersen (GED-0301) in Subjects with Active Ulcerative Colitis. Ulcerative Colitis.
MedDRA version: 18.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: Mongersen
Product Code: GED-0301
INN or Proposed INN: Mongersen
Other descriptive name: GED-0301
Celgene CorporationNULLNot RecruitingFemale: yes
Male: yes
40Phase 2United States;Hungary;Slovakia;Canada;Poland;Bulgaria
3EUCTR2015-003364-36-SK
(EUCTR)
22/01/201607/12/2015A study using a new drug (GED-0301) to investigate if the new drug works and is safe in subjects suffering ulcerative colitis.A Phase 2, Open-label, Multicenter Study to Explore the Efficacy and Safety of Mongersen (GED-0301) in Subjects with Active Ulcerative Colitis. Ulcerative Colitis.
MedDRA version: 19.0;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: Mongersen
Product Code: GED-0301
INN or Proposed INN: Mongersen
Other descriptive name: GED-0301
Celgene CorporationNULLNot RecruitingFemale: yes
Male: yes
40Phase 2United States;Hungary;Slovakia;Canada;Poland;Bulgaria
4NCT02601300
(ClinicalTrials.gov)
December 14, 20156/11/2015An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative ColitisA Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.Colitis, UlcerativeDrug: GED-0301CelgeneNULLCompleted18 YearsN/AAll41Phase 2United States;Bulgaria;Canada;Hungary;Poland;Slovakia